Novartis Institutes For Biomedical Research

Florencia Segal’s experiences prepared her to lead the rapid design of a large COVID-19 clinical trial.

Although breast cancer is one of the most visible and supported diseases in the world, the majority of public focus goes toward prevention, early detection and survival.

Novartis transforms its Global Health & Corporate Responsibility organization

News and more from the frontiers of medicine.

The page features recent and past Novartis healthcare news stories, including media releases and featured information.

Novartis describes its teams as diverse and inclusive and says they collaborate to bring products to life.

The Novartis Board of Directors is responsible for the company's direction, strategy, and administration.

Under the leadership of Vasant Narasimhan, the Executive Committee of Novartis (ECN) is responsible for overseeing the company's business operations.

Ensuring people everywhere can benefit from the latest medical breakthroughs is a shared global responsibility.

The company has received numerous awards for its work, culture, and initiatives.

Novartis says it has pursued scientific breakthroughs for more than 250 years, including 30 years as Novartis, and turns innovations into medicines for patients.

The General Privacy Notice for Business Partners defines Novartis data privacy rules for personal information collected and/or processed from business partners (healthcare professionals, customers and prospective customers).

Novartis's General Privacy Notice for Business Partners defines data privacy rules for personal information collected or processed from external stakeholders, including public officials, journalists, patient associations, and industry influencers.

The Novartis Binding Corporate Rules define the principles of international transfer of personal information.

The Novartis Privacy Hub is the entry page for all information regarding data privacy at Novartis.